AbbVie Inc.
ABBVAbbVie Inc. (ABBV) is a Healthcare company that currently yields 2.67% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $141.09 and the overvaluation threshold at $221.54. AbbVie Inc. holds a quality score of 45/100 (Average), reflecting 54 consecutive years of dividend growth. The 5-year dividend CAGR stands at 6.8%.
ABBV Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 44.2% downside to reach the Weiss buy zone
Undervaluation starts near $141.09, where the annual dividend would imply roughly 4.78% yield. That is 2.11% above today's yield.
Buy-zone price
$141.09
Target yield
4.78%
Research checklist
What to clear before buying the yield
Updated Jul 9, 2026
Dividend durability
54YLong dividend history supports a deeper look.
Earnings payout
326%Coverage deserves a closer look in filings.
Cash payout
59%Free cash flow coverage supports the payment.
Dividend growth
6.8%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-07-08 → 2026-07-09
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
AbbVie Inc. is trading near its historical overvaluation band.
Current yield 2.7% vs historical max 6.6% (41% of maximum).
12 consecutive years without a dividend cut.
Elevated payout ratio of 326%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 45/100 quality score says the headline yield needs extra skepticism.
The earnings payout ratio is above 100%, so coverage is the first risk to unpack.
ABBV Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$285
Year 10 Income
$718
Yield on Cost
7.55%
Total Income
$4,654
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what ABBV dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗ABBV Dividend Quality Score
Quality Score
Average
Key Metrics
Invest in ABBV
Buy AbbVie Inc. commission-free on eToro
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ ABBV Dividend Analysis ArticleRelated Reading
Collections